ADAP
Adaptimmune Therapeutics
ADAP
ADAP
49 hedge funds and large institutions have $259M invested in Adaptimmune Therapeutics in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 12 closing their positions.
Holders
49
Holders Change
–
Holders Change %
0%
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
12
Increased
13
Reduced
6
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–